Shares of health insurance operators surged Tuesday after the government said it would pay a higher rate to Medicare insurers than previously estimated.
The health solutions company named Brian Newman as chief financial officer and said that it expects to meet or exceed its latest guidance for the year.
CVS Health on Tuesday named United Parcel Service executive Brian Newman as its new chief financial officer, in the first top management change for the health insurer under the leadership of CEO David Joyner.
CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News reported on Monday, citing people familiar with the matter.
The Trump administration said it will raise Medicare Advantage payments sharply, good news for Humana, UnitedHealth and other health insurers. The post Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike appeared first on Investor's Business Daily.
CVS has been worst hit by the rising healthcare utilization/ medical costs, as observed in the relatively higher medical benefit ratio in FQ4'24/ FY2024 compared to its peers. Even so, we believe that FY2024 (and maybe FY2025) are likely to be its trough years, as the management offers promising guidance and the consensus raises forward estimates. Despite industry-wide issues, CVS remains well ...
I rate CVS Health as a BUY due to its undervaluation and potential for financial growth despite current sector uncertainties. CVS's revenue is growing, but profitability is declining due to retail competition and PBMs shrinking reimbursement rates. CVS's PBM business, Caremark, holds a significant market share, positioning it better than competitors like Walgreens.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.